Related Experiment Video
Updated: Jun 27, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Delayed Partial Nephrectomy After Renal Cryoablation: Whole-Lesion Histology and Clinical Course of a Single Case
Alimire Maimaitijiang1,2, Yaohui Wang2,3, Zhaopei Liu1,2
1Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Abstract:
Introduction: Cryoablation is an established nephron-sparing option for small renal masses, particularly in patients unsuitable for surgery. However, definitive histopathological assessment post-ablation is limited due to the in situ nature of treatment. This report details a case of delayed partial nephrectomy after cryoablation, enabling comprehensive histopathological evaluation of long-term treatment effects. Case presentation: A 50-year-old man with uncontrolled hypertension, diabetes, and triple-vessel coronary disease presented with a 2.5 cm right renal mass. Cardiovascular instability deferred initial surgery. Following coronary intervention requiring anticoagulation, percutaneous cryoablation was performed using CT-guided 3D reconstruction for precise probe placement and ice-ball confirmation. After 388 days, laparoscopic partial nephrectomy was performed. Histopathology revealed a 1.9 cm clear cell renal cell carcinoma. Approximately one-third of tissue showed post-cryoablation changes. Three distinct zones were identified: viable carcinoma, coagulative necrosis with preserved glomerular outlines, and viable parenchyma. Serial follow-up over 2 years showed transient creatinine elevation normalizing by 3 months, with no recurrence or metastasis. Conclusions: This case provides rare whole-lesion histopathological assessment after renal cryoablation, illustrating heterogeneous long-term tissue response and supporting cryoablation as a disease-control or bridging strategy in medically high-risk patients.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury III: Clinical Manifestations
